NTR - Nutrien Ltd.
NYSE
->
Basic Materials
->
Agricultural Inputs
Saskatoon,
Canada
Type: Equity
NTR price evolution
NTR
| (in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $909 | $508 | $724 | $361 |
| Short term investments | ||||
| Net receivables | $5398 | $7713 | $8595 | $6009 |
| Inventory | $6336 | $5169 | $6062 | $9852 |
| Total current assets | $14170 | $14092 | $15996 | $18271 |
| Long term investments | ||||
| Property, plant & equipment | $22461 | $22150 | $21920 | $21832 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $52749 | $52229 | $53926 | $56592 |
| Current liabilities | ||||
| Accounts payable | $9453 | $6615 | $9284 | $10497 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $12121 | $11312 | $12737 | $15475 |
| Long term debt | $9912 | $10328 | $10359 | $10390 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $27593 | $27084 | $28513 | $31331 |
| Shareholders' equity | ||||
| Retained earnings | $11531 | $11636 | $11823 | $11660 |
| Other shareholder equity | -$296 | -$410 | -$325 | -$383 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $909 | $775 | $499 | $1454 |
| Short term investments | $1495 | |||
| Net receivables | $5398 | $6194 | $5366 | $3581 |
| Inventory | $6336 | $7632 | $6328 | $4930 |
| Total current assets | $14170 | $16342 | $13846 | $11470 |
| Long term investments | $38579 | $703 | $562 | |
| Property, plant & equipment | $22461 | $21767 | $20016 | $19660 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $35722 | |||
| Total investments | ||||
| Total assets | $52749 | $54586 | $49954 | $47192 |
| Current liabilities | ||||
| Accounts payable | $5477 | $11291 | $5179 | $4415 |
| Deferred revenue | ||||
| Short long term debt | $2654 | $545 | $14 | |
| Total current liabilities | $12121 | $14280 | $12443 | $8480 |
| Long term debt | $9912 | $8939 | $7521 | $10047 |
| Total noncurrent liabilities | $16347 | |||
| Total debt | ||||
| Total liabilities | $27593 | $28768 | $26255 | $24827 |
| Shareholders' equity | ||||
| Retained earnings | $11531 | $11928 | $8192 | $6606 |
| Other shareholder equity | -$296 | -$391 | -$146 | -$119 |
| Total shareholder equity | $25156 | $23652 | $22365 | |
| (in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $5631 | $6107 | ||
| Cost of revenue | ||||
| Gross Profit | $1627 | $1913 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $1169 | $1120 | ||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $97 | $193 | ||
| Interest expense | -$265 | -$99 | ||
| Net income | ||||
| Net income | $75 | $571 | ||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $29056 | $37884 | $20053 | |
| Cost of revenue | $14814 | |||
| Gross Profit | $8195 | $14515 | $5239 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $3255 | |||
| Total operating expenses | $4393 | $4667 | $18531 | |
| Operating income | $1522 | |||
| Income from continuing operations | ||||
| EBIT | $1522 | |||
| Income tax expense | $670 | $2559 | -$77 | |
| Interest expense | -$681 | -$224 | -$475 | |
| Net income | ||||
| Net income | $1258 | $7660 | $459 | |
| Income (for common shares) | $459 | |||
| (in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$2958 | -$2225 | -$1552 | -$694 |
| Financing activities | ||||
| Dividends paid | -$1032 | -$770 | -$509 | -$246 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$2061 | $981 | $5 | $2129 |
| Effect of exchange rate | -$7 | -$19 | -$2 | -$5 |
| Change in cash and equivalents | $40 | -$347 | -$164 | $572 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Net income | $3153 | $459 | ||
| Operating activities | ||||
| Depreciation | $1951 | $1989 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $3886 | $3323 | ||
| Investing activities | ||||
| Capital expenditures | -$1783 | -$1423 | ||
| Investments | $438 | |||
| Total cash flows from investing | -$2958 | -$2901 | -$1807 | -$1204 |
| Financing activities | ||||
| Dividends paid | -$1032 | -$1031 | -$1045 | -$1030 |
| Sale and purchase of stock | ||||
| Net borrowings | -$1102 | -$134 | ||
| Total cash flows from financing | -$2061 | -$4731 | -$3003 | -$1339 |
| Effect of exchange rate | -$7 | -$76 | -$31 | $3 |
| Change in cash and equivalents | $40 | $402 | -$955 | $783 |
News
Fundamentals
| Market cap | $26.04B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 494.55M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | 1.84 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.10 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.17 |
| Quick ratio | 0.65 |